Rüland Anna Marlene, Hagemann Friederike, Reinisch Mattea, Holtschmidt Johannes, Kümmel Aylin, Dittmer-Grabowski Christine, Stöblen Frank, Rotthaus Horst, Dreesmann Volker, Blohmer Jens-Uwe, Kümmel Sherko
Senology/Breast Care Unit, Evangelische Huyssens-Stiftung, Kliniken Essen Mitte, Essen, Germany.
Department of Gynecology with Breast Center, Charité - Universitätsmedizin Berlin, Campus Mitte and Benjamin Franklin, Berlin, Germany.
Breast Care (Basel). 2018 Apr;13(2):116-120. doi: 10.1159/000486388. Epub 2018 Mar 9.
This study presents first feasibility experiences with a new 3-dimensional (3D) marker clip system in clinical practice. The rate of clinical complete responses in the treatment of breast cancer patients is increasing; additionally, a change to targeted axillary dissection is being considered after neoadjuvant chemotherapy (NACT). Consequently, marker clips are needed which are reliable and easy to handle even in the axillary lymph node system.
A total of 50 patients from the Breast Care Unit of the Kliniken Essen Mitte were included. Clip marking of all 50 primary breast cancer lesions as well as 23 lymph nodes was performed using the Tumark Vision® clip. Following application, the position and visibility of the marker clip were monitored and documented in 2 axes.
The feasibility of the Tumark Vision clip was excellent in everyday clinical practice as none of the markers dislocated. After clip marking of the tumor region and/or suspicious lymph nodes, all Tumark Vision clips could be detected in both axes. The 3D shape could be observed in all cases after application.
The new 3D-shaped marker clip seems to be a promising tool for marking breast cancer lesions and even lymph nodes before NACT. As there are many studies ongoing to prove the feasibility of a shift from standard axillary dissection after NACT towards targeted axillary dissection, the Tumark Vision clip seems to provide good visibility even in lymph nodes after NACT. Further studies are warranted.
本研究展示了一种新型三维(3D)标记夹系统在临床实践中的首次可行性经验。乳腺癌患者治疗中的临床完全缓解率正在上升;此外,新辅助化疗(NACT)后正在考虑转向靶向腋窝淋巴结清扫术。因此,需要一种即使在腋窝淋巴结系统中也可靠且易于操作的标记夹。
纳入了埃森米特克林iken乳腺护理单元的50名患者。使用Tumark Vision®标记夹对所有50个原发性乳腺癌病灶以及23个淋巴结进行夹标记。应用后,在两个轴向上监测并记录标记夹的位置和可视性。
在日常临床实践中,Tumark Vision标记夹的可行性极佳,因为没有一个标记夹发生移位。在对肿瘤区域和/或可疑淋巴结进行夹标记后,在两个轴向上均能检测到所有Tumark Vision标记夹。应用后在所有病例中均可观察到三维形状。
新型三维形状的标记夹似乎是在NACT前标记乳腺癌病灶甚至淋巴结的一种有前景的工具。由于有许多研究正在进行以证明NACT后从标准腋窝淋巴结清扫术转向靶向腋窝淋巴结清扫术的可行性,Tumark Vision标记夹似乎即使在NACT后的淋巴结中也能提供良好的可视性。有必要进行进一步研究。